About
CNS Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
177
By Phase
NA: 1PHASE2: 1
By Status
UNKNOWN: 1COMPLETED: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05287997Lead Sponsor
Blood Biomarker Study to Diagnose Adolescent Sport Concussion
NAUnknown
150 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2023
NCT05148884Lead Sponsor
Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia
PHASE2Completed
27 participants
Started: Nov 9, 2021 · Completed: Jan 18, 2023
Funding History (1)
D
Jul 18, 2013
Locations (1)
Headquarters
Castres, France
Map
Loading map...